BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 31123247)

  • 1. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
    Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered DLPFC-Hippocampus Connectivity During Working Memory: Independent Replication and Disorder Specificity of a Putative Genetic Risk Phenotype for Schizophrenia.
    Schneider M; Walter H; Moessnang C; Schäfer A; Erk S; Mohnke S; Romund L; Garbusow M; Dixson L; Heinz A; Romanczuk-Seiferth N; Meyer-Lindenberg A; Tost H
    Schizophr Bull; 2017 Sep; 43(5):1114-1122. PubMed ID: 28207073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.
    Kaalund SS; Newburn EN; Ye T; Tao R; Li C; Deep-Soboslay A; Herman MM; Hyde TM; Weinberger DR; Lipska BK; Kleinman JE
    Mol Psychiatry; 2014 Dec; 19(12):1258-66. PubMed ID: 24322206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Inflammatory Marker Abnormalities in Major Psychiatric Diseases: a Systematic Review of Postmortem Brain Studies.
    Ai YW; Du Y; Chen L; Liu SH; Liu QS; Cheng Y
    Mol Neurobiol; 2023 Apr; 60(4):2116-2134. PubMed ID: 36600081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder.
    Ho AM; Winham SJ; Armasu SM; Blacker CJ; Millischer V; Lavebratt C; Overholser JC; Jurjus GJ; Dieter L; Mahajan G; Rajkowska G; Vallender EJ; Stockmeier CA; Robertson KD; Frye MA; Choi DS; Veldic M
    J Psychiatr Res; 2019 Oct; 117():45-54. PubMed ID: 31279243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
    Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-mortem molecular profiling of three psychiatric disorders.
    Ramaker RC; Bowling KM; Lasseigne BN; Hagenauer MH; Hardigan AA; Davis NS; Gertz J; Cartagena PM; Walsh DM; Vawter MP; Jones EG; Schatzberg AF; Barchas JD; Watson SJ; Bunney BG; Akil H; Bunney WE; Li JZ; Cooper SJ; Myers RM
    Genome Med; 2017 Jul; 9(1):72. PubMed ID: 28754123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
    Li Z; Li D; Chen X
    J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
    Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.
    Hoseth EZ; Ueland T; Dieset I; Birnbaum R; Shin JH; Kleinman JE; Hyde TM; Mørch RH; Hope S; Lekva T; Abraityte AJ; Michelsen AE; Melle I; Westlye LT; Ueland T; Djurovic S; Aukrust P; Weinberger DR; Andreassen OA
    Schizophr Bull; 2017 Jul; 43(4):881-890. PubMed ID: 28049760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders.
    Darby MM; Yolken RH; Sabunciyan S
    Transl Psychiatry; 2016 Sep; 6(9):e890. PubMed ID: 27622934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
    Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
    Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
    Kunii Y; Hyde TM; Ye T; Li C; Kolachana B; Dickinson D; Weinberger DR; Kleinman JE; Lipska BK
    Mol Psychiatry; 2014 Feb; 19(2):192-9. PubMed ID: 23295814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings.
    Marballi K; Cruz D; Thompson P; Walss-Bass C
    PLoS One; 2012; 7(5):e36431. PubMed ID: 22590542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional coupling of M
    Odagaki Y; Kinoshita M; Meana JJ; Callado LF; García-Sevilla JA
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):869-880. PubMed ID: 31807862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
    Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.